NexOptic announced that it is nearing the point of first revenue. NexOptic Technology Corp. and Pristine Surgical LLC are in an exclusive SaaS model partnership whereby NexOptic's artificial intelligence (AI) powered imaging technology is licensed for use into Pristine's single-use endoscopic visualization platform called SummitTM.

Summit is a single-use surgical arthroscope designed to make more efficient, consistent, and safe endoscopy. NexOptic's ALIISTM provides an important AI image enhancement to optimize the surgeon's 4K surgical view. Summit is delivered in single-use, sterile packaging, is simple to set up, improves predictability and workflow, and its transparent pricing model reduces costs for ambulatory surgery centers (ASCs).

Summit also includes a proprietary cloud-based software ­ Pristine ConnectTM ­ allowing for seamless video capture, automated inventory management, and a growing portfolio of value-added services. Pristine Surgical received its FDA 510(k) clearance for SummitTM, the world's first 4K single-use surgical arthroscope in January 2023, completed its first in human procedure in April 2023 and began its limited market release in the United States shortly thereafter. Strength of revenue from NexOptic's perspective will be predicated upon the number of surgical centers that incorporate Summit into their surgical procedures.

Pristine Surgical anticipates expanding into a broader portfolio of rigid and flexible endoscopes, totaling 125 million procedures worldwide each year.